EJF Acquisition Corp. Arlington, VA 22201Underwriting Agreement • February 18th, 2021 • EJF Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 18th, 2021 Company Industry JurisdictionThis letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) to be entered into by and among EJF Acquisition Corp., a Cayman Islands exempted company (the “Company”), UBS Securities LLC and Barclays Capital Inc. (the “Representatives”) of the several underwriters (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”) of up to 28,750,000 of the Company’s units (including up to 3,750,000 units that may be purchased pursuant to the Underwriters’ option to purchase additional units, the “Units”), each comprising of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), and one-third of one redeemable warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder thereof to purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment. The Units will be sold in the Public Offering pursuant to a
WARRANT AGREEMENT between EJF ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated , 2021Warrant Agreement • February 18th, 2021 • EJF Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 18th, 2021 Company Industry JurisdictionTHIS WARRANT AGREEMENT (this “Agreement”), dated , 2021, is by and between EJF Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”).
EJF ACQUISITION CORP. 25,000,000 Units Underwriting AgreementUnderwriting Agreement • February 18th, 2021 • EJF Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 18th, 2021 Company Industry JurisdictionEJF Acquisition Corp., a Cayman Islands exempted company (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (collectively, the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 25,000,000 units of the Company (the “Underwritten Units”) and, at the option of the Underwriters, up to an additional 3,750,000 units of the Company (the “Option Units”). The Underwritten Units and the Option Units are referred to herein as the “Units.” To the extent that there are no additional Underwriters listed on Schedule 1 other than you, the term Representative as used herein shall mean you, as Underwriter, and the term Underwriter shall mean either the singular or plural as the context requires.